SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 213 filers reported holding SEATTLE GENETICS INC in Q1 2014. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $329,000 | +5.1% | 6,042 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $313,000 | -15.6% | 6,042 | +2.4% | 0.00% | 0.0% |
Q1 2017 | $371,000 | +10.7% | 5,901 | -7.0% | 0.00% | 0.0% |
Q4 2016 | $335,000 | +2.8% | 6,342 | +5.2% | 0.00% | -33.3% |
Q3 2016 | $326,000 | +35.8% | 6,031 | +1.5% | 0.00% | +50.0% |
Q2 2016 | $240,000 | +15.4% | 5,942 | +0.4% | 0.00% | 0.0% |
Q1 2016 | $208,000 | -23.0% | 5,917 | -1.7% | 0.00% | -33.3% |
Q4 2015 | $270,000 | +27.4% | 6,017 | +9.7% | 0.00% | +50.0% |
Q3 2015 | $212,000 | -20.6% | 5,487 | -0.4% | 0.00% | -33.3% |
Q2 2015 | $267,000 | -1.8% | 5,507 | -24.7% | 0.00% | 0.0% |
Q3 2014 | $272,000 | -95.5% | 7,317 | -95.4% | 0.00% | -95.9% |
Q2 2014 | $6,112,000 | -11.6% | 159,801 | +5.3% | 0.07% | -22.9% |
Q1 2014 | $6,917,000 | +14.2% | 151,826 | 0.0% | 0.10% | +9.1% |
Q4 2013 | $6,056,000 | -18.2% | 151,826 | -10.1% | 0.09% | -26.7% |
Q3 2013 | $7,405,000 | +25.6% | 168,951 | -9.9% | 0.12% | +15.4% |
Q2 2013 | $5,898,000 | – | 187,476 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |